The Stem Cell Podcast

Ep. 50: Global Perspective Featuring George Daley of the Harvard Stem Cell Institute

Aug 4, 2015
In this insightful discussion, Dr. George Daley, a renowned stem cell biologist from Harvard, shares his journey from leukemia research to leading advancements in hematopoietic stem cell transplantation. He dives into the future of generating patient-specific blood stem cells and the challenges of directed differentiation. Daley emphasizes the continued importance of embryonic research alongside iPS technology. With light-hearted lab stories, he also touches on the ethical landscape and the exciting potential of CRISPR and organoids in transforming medicine.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Bone Marrow Transplant Is Proven But Imperfect

  • Hematopoietic stem cell transplant is a longstanding, curative stem cell therapy with real-world clinical successes.
  • George Daley highlighted persistent limitations: donor mismatch, complications, and significant patient mortality remain.
INSIGHT

Human Blood Stem Cell Generation Remains Slippery

  • Generating engraftable human hematopoietic stem cells from pluripotent cells remains elusive despite mouse success.
  • Daley's lab uses transcription-factor reprogramming of progenitors to create many blood lineages and aims for full engraftable HSCs.
ADVICE

Match Reprogramming Method To Need

  • Choose reprogramming methods based on resources and application rather than a single 'best' technique.
  • Use episomal plasmids for low cost and Sendai virus when high efficiency and budget allow.
Get the Snipd Podcast app to discover more snips from this episode
Get the app